ResMed Inc.
RMD
주식 순위
#707
ResMed Inc. is a leading global medical technology enterprise engaged in the... ResMed Inc. is a leading global medical technology enterprise engaged in the creation, production, distribution, and marketing of healthcare devices and connected digital solutions. The company operates through two primary segments: Sleep and Respiratory Care, and Software as a Service. Its extensive product range addresses a variety of respiratory disorders, encompassing advanced medical and consumer technologies, ventilation devices, diagnostic equipment, mask systems for both clinical and personal use, headgear, and related accessories, alongside dental devices. ResMed also provides sophisticated cloud-based informatics to enhance patient management and operational efficiency. Notable software offerings in its respiratory portfolio include AirView, for remote device monitoring and setting adjustments; myAir, a personalized application designed to support sleep apnea patients with education and troubleshooting for better engagement and adherence; and U-Sleep, a compliance tracking platform for home medical equipment providers. Complementing these are connectivity modules and Propeller solutions. Furthermore, ResMed offers a robust suite of out-of-hospital software. This includes Brightree, a business management platform for various home care service providers (e.g., HME, pharmacy, infusion, orthotics, prosthetics); MatrixCare, providing care management for senior living, skilled nursing, and hospice organizations; and HEALTHCAREfirst, which supplies electronic health records, billing, coding services, and analytics for home health and hospice agencies. ResMed distributes its offerings primarily to sleep clinics, home healthcare dealers, and hospitals via a global network of distributors and a direct sales force, serving approximately 140 countries. Founded in 1989, the company's headquarters are located in San Diego, California.
주가
$245.56
시가총액
$34.54B
변동 (1일)
2.47%
변동 (1년)
-9.52%
국가
US
거래 ResMed Inc. (RMD)
카테고리
Healthcare
ResMed Inc. (RMD)의 P/E 비율
October 2026 기준 P/E 비율 TTM: 22.54
ResMed Inc.의 최신 재무 보고서와 주가에 따르면 현재 P/E (TTM) 비율은 22.54입니다. 2024년 말 기준 P/E 비율은 26.92였습니다.
ResMed Inc.의 P/E 비율 기록 (2000 ~ 2026)
매년 말 P/E 비율
| 연도 | P/E 비율 | 변화 |
|---|---|---|
| 2026 (TTM) | 22.54 | -16.59% |
| 2025 | 27.02 | 0.38% |
| 2024 | 26.92 | -24.65% |
| 2023 | 35.73 | -9.05% |
| 2022 | 39.28 | -47.96% |
| 2021 | 75.49 | 69.35% |
| 2020 | 44.58 | 1.83% |
| 2019 | 43.78 | -6.58% |
| 2018 | 46.86 | 45.70% |
| 2017 | 32.16 | 27.81% |
| 2016 | 25.16 | 12.14% |
| 2015 | 22.44 | 8.16% |
| 2014 | 20.75 | -0.27% |
| 2013 | 20.80 | 16.45% |
| 2012 | 17.86 | -14.08% |
| 2011 | 20.79 | -13.89% |
| 2010 | 24.14 | 14.81% |
| 2009 | 21.03 | -16.13% |
| 2008 | 25.07 | -47.48% |
| 2007 | 47.74 | 24.01% |
| 2006 | 38.49 | 10.09% |
| 2005 | 34.97 | 16.65% |
| 2004 | 29.97 | 5.79% |
| 2003 | 28.33 | 18.64% |
| 2002 | 23.88 | -82.35% |
| 2001 | 135.33 | 272.77% |
| 2000 | 36.30 | 0.00% |
유사 기업 또는 경쟁사의 P/E 비율
| 회사 | P/E 비율 | P/E 비율 차이 | 국가 |
|---|---|---|---|
| 33.11 | 46.91% |
US
|
|
| 21.39 | -5.10% |
IE
|
|
| 28.94 | 28.43% |
US
|
|
| 17.34 | -23.07% |
US
|
|
| - | - |
DE
|
P/E 비율 읽는 방법
P/E 비율은 회사의 주가와 주당순이익 간의 관계를 측정합니다.
낮지만 양수인 P/E는 현재 가치 대비 높은 수익을 내고 있는 저평가된 기업을 의미합니다. 높은 음수(0에 가까운) P/E는 큰 손실을 나타냅니다.
P/E가 30을 초과하거나 음수인 기업은 일반적으로 '성장주'로 간주되며, 투자자들은 향후 수익성 개선을 기대합니다.
양의 P/E가 10 미만인 기업은 일반적으로 '가치주'로 간주되며, 이미 매우 수익성이 높고 향후 큰 성장은 기대되지 않습니다.